Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Can We Use mTOR Inhibitors for COVID-19 Therapy?
Comb Chem High Throughput Screen. 2022;25(11):1805-1808. doi: 10.2174/1386207325666211130140923.
Comb Chem High Throughput Screen. 2022.
PMID: 34847842
Efficacy and safety of colchicine treatment in patients with COVID-19: A prospective, multicenter, randomized clinical trial.
Pourdowlat G, Saghafi F, Mozafari A, Sahebnasagh A, Abedini A, Nabi Meybodi M, Salehi Nezamabadi A, Mousavinasab SR, Kiani A, Raji H, Soltani N, Gholmzadeh Baeis M, Eidani E, Sadeghi Yakhdani A, Movaseghi F, Habtemariam S, Akhoundi Meybodi Z, Gholinataj Jelodar M.
Pourdowlat G, et al.
Phytother Res. 2022 Feb;36(2):891-898. doi: 10.1002/ptr.7319. Epub 2022 Feb 2.
Phytother Res. 2022.
PMID: 35107188
Clinical Trial.
Among 202 randomized patients, 153 completed the study and received colchicine/standard care or continued standard care (M age, 54.72 [SD, 15.03] years; 93 [63.1%] men). On day 14, patients in the colchicine/standard care group had significantly higher odds of a better cli …
Among 202 randomized patients, 153 completed the study and received colchicine/standard care or continued standard care (M age, 54.72 …
Item in Clipboard
Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary Evidence.
Hendouei N, Hosseini SH, Panahi A, Khazaeipour Z, Barari F, Sahebnasagh A, Ala S.
Hendouei N, et al.
Iran J Pharm Res. 2016 Winter;15(1):323-30.
Iran J Pharm Res. 2016.
PMID: 27610173
Free PMC article.
In this study we evaluated the relationship between S100B and leptin in schizophrenic patients under treatment with clozapine and risperidone.This study included 19 patients meeting the DSM-IV-TR criteria for schizophrenia, having body mass index (BMI) of 16- 25 kg/m(2) an …
In this study we evaluated the relationship between S100B and leptin in schizophrenic patients under treatment with clozapine and risperidon …
Item in Clipboard
Cite
Cite